[Scintigraphy with 99mTc-MIBI for assessment of tumor response to preoperative chemotherapy in patients with osteosarcoma]. / Centelleografía con 99mTc MIBI para valorar la respuesta tumoral a la quimioterapia preoperatoria en pacientes con osteosarcoma.

In osteogenic sarcoma an increase in patient survival has been observed due to improvement of diagnostic and treatment methods. The objective of the investigation was to determine the usefulness of scintigraphy with 99mTc-MIBI in comparison to clinical revaluation, in order to assess tumor response (sarcoma) to chemotherapy previous to surgery. Patients with histopathological osteogenic sarcoma that received chemotherapy were included, clinical and scintigraphy response was assessed previous to the surgery. The gold standard for comparison was the degree necrosis histopathological analysis of the surgical specimen with measurement. Twelve patients met the inclusion criteria. A was observed a higher correlation between the 99mTc-MIBI and the histopathology. vs. clinical evaluation (0.89 vs. 0.59 respectively). Likewise the sensitivity (Se) and specificity (Sp) were superior (Se and Sp = 100% vs. Se 66.6% and Sp 75%) when therapeutically responses good and null were compared. We may conclude that scintigraphy with 99mTc-MIBI used to asses the response to presurgery chemotherapy in patients with osteogenic sarcoma, together with the clinical assessment, help the physician to make therapeutically decisions with more objectivity and certainly.

[Scintigraphy with erythrocytes labelled in vitro with 99mTc compared with 111In-octreotide in the detection of carotid glomus]. / Centelleografía con eritrocitos marcados in vitro con 99mTc comparada con 111In-octreótido en la detección de glomus carotídeo.

OBJECTIVE: Demonstrate the utility of centelleography using 111In-octreotide in carotid glomus simple o multiple in comparison to erythrocytes with 99mTc calculate the sensitivity, specificity and accuracy of both test. DESIGN: Comparative survey (Diagnostic test) Place: Hospital Oncológico de Concentración del Distrito Federal (Mexico). SUBJECTS: Twenty patients sent to nuclear medicine service for carotid glomus diagnosis. MAIN MEASURES: All of the patients went under a centelleography with 111In-octreotide labeled erythrocytes. Diagnostic was confirmed with US and CAT, taking as the gold standard the selective angiography and/or histopathology. RESULTS: Using 99mTc-labeled erythrocytes resulted in; True positives 13, true negatives 3, false positive 3, false negative 1. Sensitivity 92%, specificity 50%, accuracy 80% and Using 111In-octreotide: True positive 14, true negative 6, and 100% sensitivity, specificity was obtained. CONCLUSIONS: We consider that Centelleography with 111In-octreotide must be the selected image methodology to accurately diagnose carotid glomus, previous to surgery, or in case of patients prior to radiotherapy that because of age, damage size or location can not be candidates for surgery.

[Diagnosis of breast tumors by scintigraphy versus mammography]. / Diagnóstico de tumores mamarios por centelleografía versus mastografía.

OBJECTIVE: To compare the efficacy of the breast scintigraphy with 99mTc-MIBI in the detection of breast lesions versus mammography. DESIGN: Cross sectional study. SETTING: A concentration oncologic hospital in Mexico City. PATIENTS: 56 women with a biopsy performed due to radiologic suspicion of mammary cancer were included as well as 10 normal women. MAIN PROCEDURES: Mammography, breast scintigraphy with 99mTc-MIBI, and biopsy were performed. RESULTS: Sensitivity of breast scintigraphy was 100% specificity 94.6%, PPV 90% and NPV 100%; sensitivity of the mammography was 100%, specificity 54% PPV 52.7%, and NPV 100%. CONCLUSIONS: Breast scintigraphy with 99mTc-MIBI showed a higher sensitivity and specificity than those of mammography. It was highly reliable for the diagnosis of mammary gland malignant lesions.